Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 Benefits  





2 References  





3 External links  














Multicenter trial







Add links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 
















Appearance
   

 






From Wikipedia, the free encyclopedia
 


Amulticenter research trial is a clinical trial that involves more than one independent medical institutions in enrolling and following trial participants.[1] In multicenter trials the participant institutions follow a common treatment protocol and follow the same data collection guidelines, and there is a single coordinating center that receives, processes and analyzes study data.[2][3]

Benefits[edit]

An important benefit of multicenter trials is that they permit the enrollment of a larger number of participants at a faster rate, in comparison to a single-center trial, putting to use the sources of multiple institutions.[2] This is crucial when the anticipated benefit from a treatment will be relatively small, or an expected outcome is likely to be uncommon, making a larger sample size necessary. Therefore, studies on preventive measures and therapies tend to be designed as multicenter trials. In studying novel pharmaceuticals, Phase III trials, which compare the new treatment to an established one, are usually multicenter ones. In contrast, Phase I trials, which test potential toxicity of the treatment, and Phase II trials, which establish some preliminary efficacy of the tested treatment, are usually single-center trials, as they require fewer participants.[4]

The benefits of multicenter trials also include the potential for a more heterogenous sample of participants, from different geographic locations and a wider range of population groups, treated from physicians of different backgrounds, and the ability to compare results among centers, all of which increase the generalizability of the study. In many cases, efficacy will vary significantly between population groups with different genetic, environmental, and ethnic or cultural backgrounds ("demographic" factors); multicenter trials are better at evaluating these factors, by giving the opportunity for more subgroup analyses. Heterogeneity in the sample means that the findings will be more generalizable.[4] On the other hand, a more heterogeneous study population generally requires a larger sample size to detect a given difference.[2]

References[edit]

  1. ^ Friedman, LM; Furberg, CD; et al. (2015). "Multicenter Trials". Fundamentals of Clinical Trials. Springer, Cham. p. 427. doi:10.1007/978-3-319-18539-2_21. ISBN 9783319185392. Retrieved 12 February 2024.
  • ^ a b c Meinert, CL; et al. (1986). "Single-center versus multicenter trials". Clinical Trials: Design, Conduct and Analysis (Online ed.). Oxford Academic. pp. 23–29. doi:10.1093/acprof:oso/9780195035681.003.0004. ISBN 9780199864478.
  • ^ Bryant, J; et al. (2014). "Multicenter Trials: Rationale and Examples". Wiley StatsRef: Statistics Reference Online (Online ed.). Wiley. p. 1. doi:10.1002/9781118445112.stat04947. ISBN 9781118445112. Retrieved 12 February 2024.
  • ^ a b Bryant 2014, p. 3.
  • External links[edit]


    Retrieved from "https://en.wikipedia.org/w/index.php?title=Multicenter_trial&oldid=1225057579"

    Categories: 
    Clinical research
    Clinical trials
     



    This page was last edited on 22 May 2024, at 02:54 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki